ANNINE-6plus: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 71308153 |
| MeSH ID | M0523692 |
| Synonym |
|---|
| 1151942-85-6 |
| annine-6plus |
| DTXSID20745426 |
| annine 6 plus |
| Q4653003 |
| 3-[20-(dibutylamino)-7-azoniahexacyclo[12.12.0.02,11.05,10.015,24.018,23]hexacosa-1(14),2(11),3,5(10),6,8,12,15(24),16,18(23),19,21,25-tridecaen-7-yl]propyl-trimethylazanium;dibromide |
| 1151942-85-6 (bromide) |
| 10-(dibutylamino)-2-(3-(trimethylammonio)propyl)chryseno[2,1-f]isoquinolin-2-ium bromide |
| 10-(dibutylamino)-2-[3-(trimethylammonio)propyl]-chryseno[2,1-f]isoquinolinium bromide (1:2) |
| unii-zsr3ub5rg2 |
| chryseno(2,1-f)isoquinolinium, 10-(dibutylamino)-2-(3-(trimethylammonio)propyl)-, bromide (1:2) |
| zsr3ub5rg2 , |
| 10-(dibutylamino)-2-(3-(trimethylammonio)propyl)-chryseno(2,1-f)isoquinolinium bromide (1:2) |
| AKOS040750525 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (20.26) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (20.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||